medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2011, Number 1

<< Back Next >>

Ann Hepatol 2011; 10 (1)

Prevalence and risk factors for bacterial skin infection and mortality in cirrhosis

Mohan P, Ramu B, Bhaskar E, Venkataraman J

Language: English
References: 22
Page: 15-20
PDF size: 263.63 Kb.


ABSTRACT

Background. Bacterial infections are often associated with significant morbidity and mortality in cirrhosis. The common practice of outdoor barefoot walking in the developing world may predispose cirrhotic individuals to skin infection. Aims. To determine the prevalence, risk factors, spectrum of infective organism and outcome of bacterial skin infection in cirrhosis. Methods. Consecutive newly diagnosed patients with cirrhosis (n = 200) between September 2007 and September 2008 were studied. Patients with congestive heart failure (n = 50) and chronic kidney disease (n = 50) on follow up at the same institution served as controls. Baseline demographic details, history of outdoor barefoot walking, details of skin infection along with cultures from skin and blood were obtained. The association between patient factors and risk of skin infection was evaluated using logistic regression. Results. Alcoholism was the predominant etiology for cirrhosis. (50%) Most of them were of Child B cirrhosis. Walking on barefoot was found to be similar in cases and controls. 21(10.5%) patients with cirrhosis had skin infection, three fourth of them had a history of barefoot walking. None of the controls had skin infection. Cellulitis with hemorrhagic bullae, leg ulcers, infected callosity and abscess were observed. The infective organism could be isolated in 17 patients. Escherichia coli was the most frequent organism identified. Logistic regression showed outdoor barefoot walking and serum albumin ‹ 2.5 gm/dL as risk factors for skin infection. Four patients died. Conclusion. The prevalence of skin infection in cirrhosis was 10.5% with a mortality of 19%. Escherichia coli was the commonly implicated organism. Outdoor barefoot walking was a strong risk factor for skin infection in cirrhosis.


REFERENCES

  1. Borzio M, Salerno F, Piantoni L, Cazzaniga M, Angeli P, Bissoli F, Boccia S, et al. Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study. Dig Liver Dis 2001; 33: 41-8.

  2. Brann OS. Infectious complications of cirrhosis. Curr Gastroenterol Rep 2001: 3(4): 285-92.

  3. Corredoira JM, Ariza J, Pallares R, Carratalá J, Viladrich PF, Rufí G, Verdaguer R, et al. Gram-Negative Bacillary Cellulitis in Patients with Hepatic Cirrhosis. Eur J Clin Microbiol Infect Dis 1994; 13: 19-24.

  4. Yoshida H, Hamada T, Inuzuka S, Ueno T, Sata M, Tanikawa K. Bacterial infection in cirrhosis, with and without hepatocellular carcinoma. Am J Gastroenterol 1993; 88: 2067-71.

  5. Caly WR, Strauss E. A prospective study of bacterial infections in patients with cirrhosis. J Hepatol 1993; 18: 353-58.

  6. Wong F, Bernardi M, Balk R, Christman B, Moreau R, Garcia- Tsao G, Patch D, et al. Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club. Gut 2005; 54(5): 718-25.

  7. Morris A. Cellulitis and Erysipelas. Clin Evid 2003; (9): 1804-9.

  8. Bisno AL, Stevens DL. Streptococcal infections of skin and soft tissue. N Engl J Med 1996; 334: 240-45.

  9. Yoon TY, Jung SK, Chang SH. Cellulitis due to Escherichia coli in three immunocompromised subjects. Br J Dermatol 1998; 139(5): 885-8.

  10. Castanet J, Lacour JP, Perrin C, Bodokh I, Dor JF, Ortonne JP. Escherichia coli cellulitis: two cases. Acta Derm Venereol 1992; 72(4): 310-1.

  11. Yael Horowitz, Ami D Sperber, Yaniv Almog. Gram-Negative cellulitis complicating cirrhosis. Mayo Clin Proc 2004; 79: 247-50.

  12. Liu BM, Hsiao CT, Chung KJ, Kung CT, Hung SC, Liu PP. Hemorrhagic bullae represent an ominous sign for cirrhotic patients. J Emerg Med 2008; 34(3): 277-81. E-pub 2007 Nov 5.

  13. Rimola A, Soto R, Bory F, Arroyo V, Piera C, Rodes J. Reticuloendothelial system phagocytic activity in cirrhosis and its relation to bacterial infections and prognosis. Hepatology 1984; 4: 53-8.

  14. Bjornboe M, Prytz H, Orskov F. Antibodies to intestinal microbes in serum of patients with cirrhosis of the liver. Lancet 1972; 1: 58-60.

  15. Triger DR, Wright R. Hyperglobulinaemia in liver disease. Lancet 1973; 1(7818): 1494-6.

  16. Simjee AE, Hamilton-Miller JM, Thomas HC, Brumfitt W, Sherlock S. Antibodies to Escherichia coli in chronic liver disease. Gut 1975; 16: 871-5.

  17. Staun-Olsen P, Bjorneboe M, Prytz H, Thomsen AC, Orskov F. Escherichia coli antibodies in alcohol liver disease. Correlation to alcohol consumption, alcoholic hepatitis and serum IgA. Scand J Gastroenterol 1983; 18: 889-96.

  18. Fierer J, Finley F. Deficient serum bactericidal activity against E. coli in patients with cirrhosis of the liver. J Clin Invest 1979; 63: 912-21.

  19. Dupuy A, Benchikhi H, Roujeau J-C, Bernard P, Vaillant L, Chosidow O, Sassolas B, et al. Risk factors for erysipelas of the leg (cellulitis): case-control study. BMJ 1999; 318(7198): 1591-4.

  20. Kuo CH, Changchien CS, Yang CY, Sheen IS, Liaw YF. Bacteremia in patients with cirrhosis of the liver. Liver 1991; 11(6): 334-9.

  21. Liu BM, Chung KJ, Chen CH, Kung CT, Ko SF, Liu PP, Chang HW. Risk factors for the outcome of cirrhotic patients with soft tissue infections. J Clin Gastroenterol 2008; 42(3): 312-6.

  22. de Mattos AA, Coral GP, Menti E, Valiatti F, Kramer C. Bacterial infection in cirrhotic patient. Arq Gastroenterol 2003; 40(1): 11-5. E-pub 2003 Oct.




2020     |     www.medigraphic.com